Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01832168 · ClinicalTrials.gov registry record · NA
Randomized Clinical Trial Using Amniotic Membrane in Robotic Assisted Laparoscopic Prostatectomy
A NA study, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT01832168 is a NA study that has completed, run by MiMedx Group. The registered enrollment target is 34 participants.
The verdict
NCT01832168, a NA study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the AmnioFix dehydrated human amniotic membrane is effective in protecting nerves in men receiving robotic assisted laparoscopic prostatectomies.
Interventions
- PROCEDURE Robotic Assisted Laparoscopic Prostatectomy
- OTHER Application of Absorbable Hemostat
- OTHER Application of dehydrated human amniotic membrane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01832168
The ClinicalTrials.gov registry entry for NCT01832168 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Robotic Assisted Laparoscopic Prostatectomy is the first listed.
NCT01832168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01832168 about?
NCT01832168 is a clinical study titled "Randomized Clinical Trial Using Amniotic Membrane in Robotic Assisted Laparoscopic Prostatectomy". The purpose of this study is to determine whether the AmnioFix dehydrated human amniotic membrane is effective in protecting nerves in men receiving robotic assisted laparoscopic prostatectomies.
What is the current status of trial NCT01832168?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2013-02. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01832168?
The interventions under investigation include: Robotic Assisted Laparoscopic Prostatectomy (PROCEDURE), Application of Absorbable Hemostat (OTHER), Application of dehydrated human amniotic membrane (OTHER).
Who is sponsoring clinical trial NCT01832168?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.